News
TBSI host Conference, 10 November,
view Poster ."
Scientists at TBSI discover new ways to block inflammatory cells implicated in a suite of diseases.
Ciana Diskin, lead author with senior author, Luke O’Neill
"
Initiate and Trinity COVID19 project are collaborating for EU Researchers Night.
Irish scientists among global group hunting for genetic explanation to COVID-19 resistance.
why do some people not get COVID-19?
"
Quantum chemists conjure recipe to turn gold, silver and copper into vessels of green energy.
Scientists based in TCD/TBSI are researching plants and microbes in soil and water for pharmaceuticals.
Scientists blueprint bacterial enzyme believed to play “stealthy” role in suppressing immune response.
Immunologists discover new trick used by MRSA superbug.
Dr David Finlay teams up with ONK Therapeutics to seek improved cancer therapies.
6 Irish start-ups taking to the virtual stage at BioEquity Europe. Great to see so many from TBSI involved.
TCD spin-outs Azadyne and Neuropath"
Three Trinity researchers win European Research Council Advanced Grants.
Congratulations to Danny Kelly (TBSI), one of the three recipients"
Researchers Investigate treatment of cancer cachexia in collaboration with Artelo Biosciences.
Led by Richard K Porter, Associate Professor of Biochemistry & Immunology at TBSI
Two new potential therapeutic targets for rheumatoid arthritis.
Collaborative team led by Dr Achilleas Floudas and Professor Ursula Fearon (pictured here)
Science Foundation Ireland 2020 Science Awards recognise key leaders in the Irish Research Community.
SFI Researcher of the Year Award: Kingston Mills, SFI Outstanding Contribution to STEM communications: Luke O Neill
Is reaching zero COVID-19 possible?.
by Kingston Mills
Landmark deal for UQ-Trinity inflammation startup.
Uniquest news.